Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PrOspective inteRventional Study Exploring the mIcrobiota recolONization in Steroid-Refractory Graft-versus-Host Disease Patients Receiving MaaT013

NCT05017688 is registered in ClinicalTrials.gov with MaaT Pharma as lead sponsor.

NCT NCT05017688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05017688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PrOspective inteRventional Study Exploring the mIcrobiota recolONization in Steroid-Refractory Graft-versus-Host Disease Patients Receiving MaaT013
Lead sponsor
MaaT Pharma
Phase
Not applicable
Overall status
Unknown status
Start date
October 6, 2021
Completion date
December 31, 2024
Enrollment
40 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

intestinal gvhd, steroid refractory gvhd